Cara Therapeutics

$14.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-0.66%) Today

$0.00 (0.00%) As of 5:37 AM EST after-hours

Why Robinhood?

You can buy or sell CARA and other stocks, options, and ETFs commission-free!

About CARA

Cara Therapeutics, Inc. Common Stock, also called Cara Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT. The listed name for CARA is Cara Therapeutics, Inc. Common Stock.

CEO

Derek T. Chalmers

Employees

Headquarters

Stamford, Connecticut

Founded

2004

Market Cap

744.99M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

437.55K

High Today

$15.19

Low Today

$14.85

Open Price

$15.06

Volume

154.22K

52 Week High

$26.67

52 Week Low

$8.88

Collections

Biotechnology

Health

Medical

Research And Development

Analyst Ratings

88%

of 8 ratings

Buy

88%

Hold

13%

Sell

CARA Earnings

-$0.74

-$0.49

-$0.25

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 25, After Hours